Moreover, the downregulation of the RAS-GAP RASA1 in a large percentage of breast cancer cases [42] and a small percentage of cases with KRAS mutations [8] suggests that RAS hyperactivity commonly drives breast cancer cases overall [43]. The gene discussed is KRAS; the disease is breast carcinoma.